Bayer closes on divestiture of interventional device business to Boston Scientific
Bayer HealthCare closed on the divestiture of its Interventional device business to Boston Scientific. The total consideration for the transaction, including fees for transitional services, is $415 million (about EUR 300 million). September 02, 2014